FFCP PHASE2:Hg19::chr20:50159198..50159299,-
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p1@NFATC2 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_1_at_NFATC2_5end |
Coexpression cluster: | NA |
Association with transcript: | 0bp_to_ENST00000371564, ENST00000396009, NM_012340, NM_173091, uc002xwc.2, uc002xwd.2, uc010zyv.1, uc010zyw.1_5end |
EntrezGene: | NFATC2 |
HGNC: | 7776 |
UniProt: | Q13469B5B2N8B5B2P3 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p1@NFATC2 |
---|
0
25
50
75
100
125
150
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
hematopoietic stem cell | 9.89e-31 | 168 |
hematopoietic cell | 1.21e-29 | 177 |
hematopoietic oligopotent progenitor cell | 1.62e-28 | 161 |
hematopoietic multipotent progenitor cell | 1.62e-28 | 161 |
lymphocyte | 1.05e-26 | 53 |
common lymphoid progenitor | 1.05e-26 | 53 |
lymphoid lineage restricted progenitor cell | 2.87e-26 | 52 |
leukocyte | 8.81e-23 | 136 |
hematopoietic lineage restricted progenitor cell | 3.01e-18 | 120 |
nongranular leukocyte | 2.78e-16 | 115 |
Showing 1 to 10 of 23 entries
Ontology term | p-value | n |
---|---|---|
adult organism | 4.77e-24 | 114 |
blood | 1.15e-10 | 15 |
haemolymphatic fluid | 1.15e-10 | 15 |
organism substance | 1.15e-10 | 15 |
hemolymphoid system | 1.96e-08 | 108 |
hematopoietic system | 3.56e-07 | 98 |
blood island | 3.56e-07 | 98 |
Showing 1 to 7 of 7 entries
Ontology term | p-value | n |
---|---|---|
hematologic cancer | 1.30e-09 | 51 |
immune system cancer | 1.30e-09 | 51 |
leukemia | 4.41e-09 | 39 |
myeloid leukemia | 3.86e-07 | 31 |
Showing 1 to 4 of 4 entries